Expertise in
24
conditions

Dr. John Reynolds

Hematology
Merle West Hematology Oncology Physicians
2610 Uhrmann Rd, 
Klamath Falls, OR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
24
conditions
Merle West Hematology Oncology Physicians
2610 Uhrmann Rd, 
Klamath Falls, OR 

Overview

John Reynolds is a Hematologist practicing medicine in Klamath Falls, Oregon.

Dr. Reynolds is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, Familial Colorectal Cancer, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 3 clinical trials.

Specialties

Hematology

Licenses

Internal Medicine in ND

Hospital Affiliations

Lake District Hospital
Modoc Medical Center
Sky Lakes Medical Center
Mckenzie County Healthcare Systems Inc

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

ATRIO Health
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Sanford Health
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 4 Less Insurance Carriers -

Locations

Merle West Hematology Oncology Physicians
2610 Uhrmann Rd, Klamath Falls, OR 97601
Other Locations
Essentia Health-St. Joseph's Medical Center
523 N 3rd St, Brainerd, MN 56401

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Enrollment Status: Recruiting
Publish Date: May 29, 2026
Intervention Type: Drug
Study Drugs: Crizotinib, Palbociclib, Sunitinib, Temsirolimus, Trastuzumab and Pertuzumab, Vemurafenib and Cobimetinib, Regorafenib, Olaparib, Pembrolizumab, Nivolumab and Ipilimumab, Abemaciclib, Afatinib, Talazoparib, Atezolizumab and PHESGO, Atezolizumab and Talazoparib, Entrectinib, Larotrectinib, Tucatinib plus Trastuzumab Subcutaneous (SC)
Study Phase: Phase 2
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 24, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
Phase Ib Study of Pembrolizumab in Combination With Chemo Radiotherapy (CRT) for Locally-advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Phase Ib Study of Pembrolizumab in Combination With Chemo Radiotherapy (CRT) for Locally-advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Enrollment Status: Completed
Publish Date: October 07, 2025
Intervention Type: Radiation, Drug
Study Drugs: Pembrolizumab, Cisplatin
Study Phase: Phase 1
View 2 Less Clinical Trial

1 Total Publications

Irradiation of donor mononuclear cells for treatment of chemorefractory metastatic solid cancers: a community-based immune transplant pilot study.
Irradiation of donor mononuclear cells for treatment of chemorefractory metastatic solid cancers: a community-based immune transplant pilot study.
Journal: Cancer research and treatment
Published: March 08, 2012
Similar Doctors
Expertise in
60
conditions
Expertise in
60
conditions
Referral may be required

Hematology Oncology Associates P.C.

3011 E Barnett Rd, 
Medford, OR 
 (53.3 miles away)
541-789-4673
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mujahid Rizvi is a Hematologist practicing medicine in Medford, Oregon. Dr. Rizvi is highly rated in 60 conditions, according to our data. His clinical expertise encompasses Appendix Cancer, Reticuloendotheliosis, Hairy Cell Leukemia (HCL), Lynch Syndrome, and Bone Marrow Aspiration.

Expertise in
70
conditions
Expertise in
70
conditions
Referral may be required

Hematology Oncology Associates P.C.

3011 E Barnett Rd, 
Medford, OR 
 (53.3 miles away)
541-789-4673
Languages Spoken:
English
See accepted insurances

Brett Poisson is a Hematologist practicing medicine in Medford, Oregon. Dr. Poisson is highly rated in 70 conditions, according to our data. His clinical expertise encompasses Gaucher Disease, Gaucher Disease Type 3, Gaucher Disease Type 1, and Gaucher Disease Type 2.

Expertise in
45
conditions
Dr. Ashish Dwary
Hematology
Expertise in
45
conditions
Dr. Ashish Dwary
Hematology
Referral may be required

Hematology Oncology Associates P.C.

3011 E Barnett Rd, 
Medford, OR 
 (53.3 miles away)
541-789-4673
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ashish Dwary is a Hematologist practicing medicine in Medford, Oregon. Dr. Dwary is highly rated in 45 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Appendix Cancer, and Colorectal Cancer.

Frequently Asked Questions about Dr. John Reynolds

How do I make an appointment with Dr. John Reynolds?

You can book an appointment with Dr. John Reynolds by calling their office at 541-274-4171. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. John Reynolds a top-rated expert for Adult Immune Thrombocytopenia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. John Reynolds is classified as an Advanced expert for Adult Immune Thrombocytopenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. John Reynolds specialize in?

While Dr. John Reynolds is a Hematology, they have specific expertise in Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, and Thrombocytopenia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. John Reynolds participate in research or clinical trials?

Yes. Dr. John Reynolds has published 1 articles and abstracts on conditions like Adult Immune Thrombocytopenia. You can view a list of Dr. John Reynolds's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. John Reynolds accept my insurance?

Dr. John Reynolds accepts most major insurance plans, including ATRIO Health and Blue Cross Blue Shield. We recommend calling the office directly at 541-274-4171 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Reynolds's expertise for a condition
ConditionClose
      View All 24 Advanced Conditions
      View All 112 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile